| Drug | Class | Adult | Paediatric | Notes |
|---|---|---|---|---|
| Ferrous sulphate[1] | Iron salt (oral) | 200 mg PO TDS (60 mg elemental iron each); or alternate-day single dose | Per local protocol | First-line oral iron; widely available, low cost; nausea, constipation common — alternate-day improves tolerance and absorption; iron polymaltose better tolerated alternative |
| Ferrous ascorbate[1] | Iron salt with vitamin C (oral) | 100 mg elemental iron PO BD | — | Indian-market alternative with claimed better absorption due to integrated ascorbic acid; well-tolerated; cost similar to ferrous sulphate |
| Ferric carboxymaltose (IV)[1] | Parenteral iron — high-dose single infusion | 750–1000 mg IV single dose; can repeat at 7 days for total iron deficit (max 2000 mg total) | — | Single-dose convenience; rapid repletion; phosphate decline at 1–2 weeks (rarely symptomatic); hypersensitivity rare |
| Iron sucrose (IV)[1] | Parenteral iron — multi-dose | 200 mg IV per session × 5 sessions to total dose calculated by Ganzoni formula | 1–2 mg/kg per session | Widely available alternative; multiple sessions; lower hypersensitivity than older iron preparations |
| Iron isomaltoside / ferric derisomaltose (IV)[1] | Parenteral iron — high-dose single infusion | Up to 20 mg/kg IV single infusion | — | Single-dose alternative to ferric carboxymaltose; lower phosphate decrement signal; hypersensitivity rare |
Diagnosis, oral and intravenous iron repletion, and aetiology workup for iron deficiency anaemia in non-pregnant adults.